{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
US Approved Rx
(2007)
First approved in 2007
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2006)
Source:
NDA021026
(2006)
Source URL:
First approved in 2006
Source:
NDA021026
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2014)
First approved in 2006
Source:
GARDASIL by MERCK AND CO INC DIV MERCK SHARP AND DOHME
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2005)
First approved in 2005
Source:
BLA125109
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2000)
First approved in 2000
Source:
BLA103788
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2000)
First approved in 2000
Source:
BLA103788
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2000)
First approved in 2000
Source:
BLA103788
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(2000)
First approved in 2000
Source:
BLA103788
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1999)
Source:
BLA020744
(1999)
Source URL:
First approved in 1999
Source:
BLA020744
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1999)
First approved in 1998
Source:
BLA103869
Source URL:
Class:
STRUCTURALLY DIVERSE